Contrast-Induced Kidney Injury Prediction in STEMI Patients Post-Coronary Intervention

Eldar B. Saparov 1 * , Aruna S. Saparova 2, Miras M. Mugazov 3
More Detail
1 Doctoral student, Department emergency medicine, anesthesiology and resuscitation, NAO "Karaganda Medical University", Karaganda, Kazakhstan
2 Trainer of the Center of Practical Skills, NAO "Karaganda Medical University", Karaganda, Kazakhstan
3 Department of Emergency Medicine, Anesthesiology and Resuscitation NAO "Karaganda Medical University", Karaganda, Kazakhstan
* Corresponding Author
J CLIN MED KAZ, Volume 22, Issue 3, pp. 79-83. https://doi.org/10.23950/jcmk/16450
OPEN ACCESS 88 Views 30 Downloads
Download Full Text (PDF)
Author Contributions: Conceptualization, M. M. M.; methodology, M. M. M.; resources, – not applicable; writing – original draft preparation, E. B. S.; writing – review and editing, A. S. S.; project administration, M. M. M.; funding acquisition – not applicable. All authors have read and agreed to the published version of the manuscript.

Data availability statement: The corresponding author can provide the data supporting the study's conclusions upon request. Due to ethical and privacy constraints, the data are not publicly accessible.

ABSTRACT

Abstract
Introduction: Contrast-induced acute kidney injury (CI-AKI) is a significant complication following percutaneous coronary intervention (PCI) in patients with ST-elevation myocardial infarction (STEMI). This study aims to develop a predictive model for CI-AKI using clinical and laboratory data.
Methods: A retrospective cohort study analyzed 63 STEMI patients undergoing PCI between November 2024 and March 2025. Data included demographics, clinical parameters, and pre- and post-intervention laboratory markers. CI-AKI was defined as a ≥25% increase in serum creatinine within 48 hours post-PCI. Logistic regression and R software (version 4.3.1) were used for statistical analysis and modeling, with performance assessed via AUC-ROC.
Results: CI-AKI occurred in 19% of patients (12/63). Key predictors were age (OR 1.06, p=0.03), baseline creatinine (OR 1.82, p=0.01), and contrast dose (OR 1.01, p=0.04). The model achieved an AUC-ROC of 0.82 (95% CI: 0.70-0.93). CI-AKI patients had higher baseline creatinine (103.5 vs. 85.2 µmol/L, p=0.02) and older age (68.4 vs. 61.2 years, p=0.04).
Conclusion: The model effectively predicts CI-AKI risk in STEMI patients post-PCI, highlighting age, creatinine, and contrast dose as critical factors. Prospective validation is needed.
Keywords: Contrast-induced kidney injury, STEMI, percutaneous coronary intervention, predictive modeling, creatinine
Keywords: Contrast-induced kidney injury, STEMI, percutaneous coronary intervention, predictive modeling, creatinine

CITATION

Saparov EB, Saparova AS, Mugazov MM. Contrast-Induced Kidney Injury Prediction in STEMI Patients Post-Coronary Intervention. J CLIN MED KAZ. 2025;22(3):79-83. https://doi.org/10.23950/jcmk/16450

REFERENCES

  • McCullough PA. Contrast-induced acute kidney injury. Journal of the American College of Cardiology. 2008; 51: 1419–1428. https://doi.org/10.1016/j.jacc.2007.12.035
  • Rihal CS, Textor SC, Grill DE, Berger PB, Ting HH, Best PJ, Singh M, Bell MR, Holmes DR Jr. Incidence and prognostic importance of acute renal failure after PCI. Circulation. 2002; 105: 2259–2264. https://doi.org/10.1161/01.cir.0000016043.87291.33
  • Dangas G, Iakovou I, Nikolsky E, Aymong ED, Mintz GS, Kipshidze NN, Lansky AJ, Moussa I, Stone GW, Moses JW, Leon MB. Contrast-induced nephropathy after PCI in patients with and without chronic kidney disease. Journal of the American College of Cardiology. 2005; 45: 1756–1762. https://doi.org/10.1016/j.jacc.2005.02.061
  • Marenzi G, Assanelli E, Marana I, Lauri G, Campodonico J, Grazi M, De Metrio M, Galli S, Fabbiocchi F, Montorsi P, Veglia F, Bartorelli AL. CI-AKI in STEMI patients. European Heart Journal. 2009; 30: 2420–2428. https://doi.org/10.1093/eurheartj/ehp290
  • Solomon R. Contrast-induced nephropathy: Update. Kidney International. 2010; 77: 587–592. https://doi.org/10.1038/ki.2009.524
  • Weisbord SD, Hartigan PM, Fleisher LA, Palevsky PM. Incidence and outcomes of contrast-induced AKI following computed tomography. Clinical Journal of the American Society of Nephrology. 2008; 3: 1274–1281. https://doi.org/10.2215/CJN.00900208
  • Tsai TT, Patel UD, Chang TI, Kennedy KF, Masoudi FA, Matheny ME, Kosiborod M, Amin AP, Messenger JC, Rumsfeld JS, Spertus JA. Contemporary incidence, predictors, and outcomes of acute kidney injury in STEMI patients. JACC: Cardiovascular Interventions. 2014; 7: 1–9. https://doi.org/10.1016/j.jcin.2013.06.016
  • Rudnick MR, Goldfarb S, Wexler L, Ludbrook PA, Murphy MJ, Halpern EF, Hill JA, Winniford M, Cohen MB, VanFossen DB. Nephrotoxicity of ionic and nonionic contrast media in 1196 patients. Kidney International. 1995; 47: 254-261. https://doi.org/10.1038/ki.1995.32
  • Heyman SN, Rosenberger C, Rosen S. Pathophysiology of radiocontrast nephropathy. Investigative Radiology. 2005; 40: 691–697. https://doi.org/10.1097/01.rli.0000181728.92728.15
  • James MT, Samuel SM, Manning MA, Tonelli M, Ghali WA, Faris P, Knudtson ML, Pannu N. Acute kidney injury following coronary angiography is associated with a long-term decline in kidney function. Kidney International. 2010; 78: 803–809. https://doi.org/10.1038/ki.2010.258
  • Tumlin J, Stacul F, Adam A, Becker CR, Davidson C, Lameire N, McCullough PA. Pathophysiology of contrast-induced nephropathy. The American Journal of Cardiology. 2006; 98: 14K–20K. https://doi.org/10.1016/j.amjcard.2006.01.017
  • Heinrich MC, Häberle L, Müller V, Bautz W, Uder M. Nephrotoxicity of iso-osmolar versus low-osmolar contrast media. Investigative Radiology. 2009; 44: 1–8. https://doi.org/10.1097/RLI.0b013e31818f79ee
  • Sgura FA, Bertelli L, Monopoli D, Vecchi G, Valgimigli M, Politi L, Tondi S, Rossi R, Modena MG. Incidence of CI-AKI in patients with acute myocardial infarction undergoing primary PCI. International Journal of Cardiology. 2010; 145: 295–296. https://doi.org/10.1016/j.ijcard.2009.11.015
  • Nikolsky E, Mehran R, Dangas G, Fahy M, Na Y, Pocock SJ, Lansky AJ, Stone GW. Impact of chronic kidney disease on prognosis of patients with diabetes undergoing PCI. The American Journal of Cardiology. 2004; 94: 300–305. https://doi.org/10.1016/j.amjcard.2004.04.022
  • Gurm HS, Dixon SR, Smith DE, Share D, Lalonde T, Moscucci M, Riba AL, Grossman PM. Renal function-based contrast dosing to define safe limits of radiographic contrast media in patients undergoing PCI. Journal of the American College of Cardiology. 2011; 58: 907–914. https://doi.org/10.1016/j.jacc.2011.05.023
  • Brown JR, McCullough PA, Splaine ME, Davies L, Ross CS, Robb JF, Malenka DJ. Does safe dosing of iodinated contrast prevent CI-AKI? Circulation: Cardiovascular Interventions. 2013; 6: 641–648. https://doi.org/10.1161/CIRCINTERVENTIONS.113.000610
  • Allen DW, Ma B, Leung KC, Graham MM, Pannu N, Traboulsi M, Goodhart D, Knudtson ML, James MT. Risk prediction models for contrast-induced nephropathy. Journal of the American Society of Nephrology. 2017; 28: 2285–2293. https://doi.org/10.1681/ASN.2016111238
  • Mehran R, Aymong ED, Nikolsky E, Lasic Z, Iakovou I, Fahy M, Mintz GS, Lansky AJ, Moses JW, Stone GW, Leon MB, Dangas G. A simple risk score for prediction of CI-AKI after PCI. Journal of the American College of Cardiology. 2004; 44: 1393–1399. https://doi.org/10.1016/j.jacc.2004.06.068
  • Maioli M, Toso A, Leoncini M, Gallopin M, Tedeschi D, Micheletti C, Bellandi F. Pre-procedural bioimpedance vector analysis improves prediction of CI-AKI. European Heart Journal. 2011; 32: 1798–1805. https://doi.org/10.1093/eurheartj/ehr072
  • Amin AP, Bach RG, Carrell DS, Kennedy KF, Messenger JC, Spertus JA, Wasfy JH, Yeh RW. Acute kidney injury after PCI: A meta-analysis. Journal of the American College of Cardiology. 2016; 67: 1755–1765. https://doi.org/10.1016/j.jacc.2016.01.055
  • Narula A, Mehran R, Weisz G, Dangas GD, Yu J, Genereux P, Nikolsky E, Brener SJ, Witzenbichler B, Guagliumi G, Stone GW. Contrast-induced acute kidney injury in STEMI: Incidence and outcomes. JACC: Cardiovascular Interventions. 2014; 7: 1011–1018. https://doi.org/10.1016/j.jcin.2014.04.013
  • Shacham Y, Leshem-Rubinow E, Steinvil A, Keren G, Roth A, Arbel Y. Long-term prognosis of CI-AKI in STEMI patients undergoing primary PCI. The American Journal of Cardiology. 2015; 115: 164–169. https://doi.org/10.1016/j.amjcard.2014.10.019
  • Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney International Supplements. 2012; 2: 1–138. https://doi.org/10.1038/kisup.2012.1
  • Marenzi G, Ferrari C, Marana I, Assanelli E, De Metrio M, Teruzzi G, Veglia F, Fabbiocchi F, Montorsi P, Bartorelli AL. Prevention of contrast nephropathy by furosemide with matched hydration. JACC: Cardiovascular Interventions. 2012; 5: 90–97. https://doi.org/10.1016/j.jcin.2011.08.017
  • McCullough PA, Wolyn R, Rocher LL, Levin RN, O’Neill WW. Baseline renal function as predictor of CI-AKI. The American Journal of Cardiology. 2006; 98: 1469–1473. https://doi.org/10.1016/j.amjcard.2006.06.052
  • Kooiman J, Klok FA, Mos IC, van der Molen AJ, Dekker FW, Rabelink TJ, Huisman MV, Leiner T. Contrast-induced acute kidney injury and renal function decline. Radiology. 2013; 269: 136–142. https://doi.org/10.1148/radiol.13122252
  • Denic A, Glassock RJ, Rule AD. The aging kidney revisited: A systematic review. Kidney International. 2016; 89: 740–750. https://doi.org/10.1016/j.kint.2015.12.035
  • Liss P, Persson PB, Hansell P, Lagerqvist B. Renal effects of contrast media in a rat model. Acta Radiologica. 2005; 46: 368–374. https://doi.org/10.1080/02841850510021274
  • Bartholomew BA, Harjai KJ, Dukkipati S, Boura JA, Yerkey MW, Glazier S, Grines CL, O’Neill WW. Impact of nephropathy after PCI and a method for risk stratification. The American Journal of Cardiology. 2004; 93: 1515–1519. https://doi.org/10.1016/j.amjcard.2004.03.008
  • Mehran R, Caixeta A, Dangas G, Lansky AJ, Parise H, Fahy M, Cristea E, Stone GW, Nikolsky E. Contrast-induced nephropathy risk score validation in STEMI. JACC: Cardiovascular Interventions. 2010; 3: 541–548. https://doi.org/10.1016/j.jcin.2010.01.017